It is specifically listed as a raw material or intermediate for the synthesis of the final active pharmaceutical ingredient, Flavoxate HCl. Flavoxate HCl is a prescription medication used to treat symptoms of overactive bladder and other urinary tract inflammatory disorders, such as dysuria, urgency, nocturia, and incontinence. Methyl 5-bromo-2-hydroxy-3-propionylbenzoate serves as a key pharmaceutical intermediate in the manufacturing process of Flavoxate HCl.
Methyl 5-bromo-2-hydroxy-3-propionylbenzoate
| API Name | Flavoxate hydrochloride |
|---|---|
| CAS No | 91099-82-0 |
| Molecular Formula | C11H11BrO4 |
| Molecular Weight | 287.11 g/mol |
| Synonyms | methyl 5-bromo-2-hydroxy-3-propanoylbenzoate |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It is specifically listed as a raw material or intermediate for the synthesis of the final active pharmaceutical ingredient, Flavoxate HCl. Flavoxate HCl is a prescription medication used to treat symptoms of overactive bladder and other urinary tract inflammatory disorders, such as dysuria, urgency, nocturia, and incontinence. Methyl 5-bromo-2-hydroxy-3-propionylbenzoate serves as a key pharmaceutical intermediate in the manufacturing process of Flavoxate HCl.
The CAS number of Methyl 5-bromo-2-hydroxy-3-propionylbenzoate is 91099-82-0.
The molecular formula of Methyl 5-bromo-2-hydroxy-3-propionylbenzoate is C11H11BrO4.
The listed molecular weight of Methyl 5-bromo-2-hydroxy-3-propionylbenzoate is 287.11 g/mol.
Methyl 5-bromo-2-hydroxy-3-propionylbenzoate is listed as being used in connection with the following API: Flavoxate hydrochloride.
The listed synonym or IUPAC name for Methyl 5-bromo-2-hydroxy-3-propionylbenzoate is methyl 5-bromo-2-hydroxy-3-propanoylbenzoate.